Stomach Cancer Trial, Recruiting NCT07525765 Sponsor: First Affiliated Hospital of Zhejiang University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07525765
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with stomach (gastric) cancer, confirmed through laboratory testing of tissue samples
  • People who have had surgery to remove part or all of the stomach as a cancer treatment
  • People who are willing and able to provide written consent to participate (required for the forward-looking part of the study)
  • People for whom complete medical records are available before surgery and for at least 15 days after surgery
  • People with no history of any other type of primary cancer

Who may not be able to join:

  • People whose stomach surgery was not intended to fully remove the cancer, or who had emergency surgery
  • People whose medical records have more than 20% of important data fields missing
  • People who had a serious infection or organ failure before their surgery
  • People who are unwilling or unable to attend follow-up appointments as required (this applies to the forward-looking part of the study only)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jichao Qin, M.D., Zhejiang University

Phone: 86+15968774033

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Zhejiang University
Registry
ClinicalTrials.gov
Start date
10 April 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

predictive performance of the deep learning model for identifying patients at high risk of postoperative bleeding requiring re-operation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov